A missed protective drug–drug interaction of DPP-4 inhibitors and statins on myopathy risk
Letter to the Editor
- 22 Downloads
Compliance with ethical standards
Conflict of interest
Both authors declare that there are no competing interests.
- 1.Antonazzo IC, Poluzzi E, Forcesi E, Salvo F, Pariente A, Marchesini G, De Ponti F, Raschi E (2019) Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system. Acta Diabetol. https://doi.org/10.1007/s00592-019-01378-7 CrossRefPubMedGoogle Scholar
© Springer-Verlag Italia S.r.l., part of Springer Nature 2019